Estimation of cardiovascular risk: A comparison between the Framingham and the SCORE model in people under 60 years of age

European Journal of Preventive Cardiology

Volumn 15, Issue 5, 2008, Pages 562-566

  Scheltens, Tjarda ^a   Verschuren, W m Monique ^b   Boshuizen, Hendriek C ^b   Hoes, Arno W ^a   Zuithoff, Nicolaas P ^a   Bots, Michiel L ^a   Grobbee, Diederick E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

cardiovascular diseases; cohort studies; forecasting; risk factors

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; MORTALITY; NETHERLANDS; PRACTICE GUIDELINE; PREDICTION AND FORECASTING; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; ADULT; AGE DISTRIBUTION; AGED; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; FRAMINGHAM MODEL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTION; PRIORITY JOURNAL; RISK MANAGEMENT; SCORE SYSTEM; TREATMENT INDICATION;

CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS;

ANTILIPEMIC AGENT; CARDIOVASCULAR AGENT;

EID: 58149378257     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3283063a65     Document Type: Article

References (29)

1. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998; 140: 199–270.
2. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293–298.
3. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002; 105: 310–315.
4. Tunstall-Pedoe H. The Dundee coronary risk-disk for management of change in risk factors. BMJ 1991; 303: 744–747.
5. Shaper AG, Pocock SJ, Phillips AN, Walker M. Identifying men at high risk of heart attacks: strategy for use in general practice. Br Med J (Clin Res Ed) 1986; 293: 474–479.
6. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.
7. Smulders YM, Spijkerman AM, Kostense PJ, Bouter LM, Stehouwer CD. Old and new scoring systems for assessing cardiovascular risks: problems with the validity, the precision and the homogenicity of the risk categories. Ned Tijdschr Geneeskd 2004; 148: 2480–2484.
8. Neuhauser HK, Ellert U, Kurth BM. A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998. Eur J Cardiovasc Prev Rehabil 2005; 12: 442–450.
9. Hoeymans N, Smit HA, Verkleij H, Kromhout D. Cardiovascular risk factors in relation to educational level in 36 000 men and women in The Netherlands. Eur Heart J 1996; 17: 518–525.
10. Vliet AL, Van den Hof S, Elvers LH, Ocké MC, Vossenaar M, Seidell JC et al. Risk factors and health in the Netherlands: a survey on municipal health services. National Institute for Public Health and the Environment; 2003 May 7. Report no. 260854004/2003.
11. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 1979; 110: 281–290.
12. Van den Hoogen JP, Van Kruijsdijk MC, Van Ree JW, Mokkink HG, Thien T, Van Weel C. Prevalence of left ventricular hypertrophy as assessed by electrocardiogram in treated hypertensive persons in general practice. J Hum Hypertens 1993; 7: 473–477.
13. Govindarajulu U, Sullivan L, D'Agostino B. SAS macros for confidence interval estimation for CHD risk prediction by different survival models. Comp Stat Data Anal 2004; 46: 571–592.
14. Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982; 115: 92–106.
15. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001; 286: 180–187.
16. The Dutch Institute for Healthcare Improvement CBO, Dutch College of General Practitioners. Multidisciplinary guideline cardiovascular risk management. Utrecht: van Zuiden Communications; 2006.
17. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003; 24: 1601–1610.
18. Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 327: 1267.
19. Empana JP, Ducimetiere P, Arveiler D, Ferrieres J, Evans A, Ruidavets JB et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 2003; 24: 1903–1911.
20. Hense HW, Schulte H, Lowel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany: results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003; 24: 937–945.
21. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000; 21: 365–370.
22. Orford JL, Sesso HD, Stedman M, Gagnon D, Vokonas P, Gaziano JM. A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study. Am Heart J 2002; 144: 95–100.
23. Thomsen TF, McGee D, Davidsen M, Jorgensen T. A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 2002; 31: 817–822.
24. Liu J, Hong Y, D'Agostino RB Sr, Wu Z, Wang W, Sun J et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 2004; 291: 2591–2599.
25. Boudik F, Reissigova J, Hrach K, Tomeckova M, Bultas J, Anger Z et al. Primary prevention of coronary artery disease among middle aged men in Prague: twenty-year follow-up results. Atherosclerosis 2006; 184: 86–93.
26. Ulmer H, Kollerits B, Kelleher C, Diem G, Concin H. Predictive accuracy of the SCORE risk function for cardiovascular disease in clinical practice: a prospective evaluation of 44 649 Austrian men and women. Eur J Cardiovasc Prev Rehabil 2005; 12: 433–441.
27. Bhopal R, Fischbacher C, Vartiainen E, Unwin N, White M, Alberti G. Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data. J Public Health (Oxf) 2005; 27: 93–100.
28. Liao Y, McGee DL, Cooper RS, Sutkowski MB. How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts. Am Heart J 1999; 137: 837–845.
29. Wood D. The treatment potential in preventive cardiology Atherosclerosis 2001; 2 (Suppl):3–8.